Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.

Mark S. Sands, Jane E. Barker, Carole Vogler, Beth Levy, Babette Gwynn, Nancy Galvin, William S. Sly, E H BirkenmeierPubMed 1993

Abstract

BMT is a more effective therapy for MPS VII when it is performed at birth rather than in adults. Alternate means of ablating host hematopoietic stem cells should be employed as a pretreatment for BMT due to the severe side effects of radiation on newborns.
BibTeX
@inproceedings{sands1993treatment,
  author = {Mark S. Sands and Jane E. Barker and Carole Vogler and Beth Levy and Babette Gwynn and Nancy Galvin and William S. Sly and E H Birkenmeier},
  title = {{Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.}},
  booktitle = {PubMed},
  year = {1993},
}

Loading related content...

Figure